Search
Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.
Tune in to today’s “MSK Science Spotlight.” The April 20 lecture, “A Single Cell Lens into the Roles of Cellular Plasticity in Development and Cancer,” will feature Dana Pe’er, PhD.
Three second-year students -- Neha Bhagwat, John Halliday, and Ellen Hukkelhoven -- received Geoffrey Beene Graduate Student Fellowships.
The 2016 GSK Experimental Therapeutics Symposium will be held at MSKCC this fall in continuation of the former Med into Grad Program.
Melanie Steele, Director of Patient Financial Engagement at Memorial Sloan Kettering, answers key questions you might have about health insurance heading into 2021.
Research presented at the 2018 meeting of the American Society of Clinical Oncology showed that the relapse rate is low for melanoma patients treated with immunotherapy, but those who do relapse can respond a second time to immunotherapy. Dr. Chapman discusses the impact. (June 2018)
Memorial Sloan Kettering Cancer Center (MSK) announced that pediatric oncologist Richard Gilbertson, MBBS, PhD, of Cancer Research UK Cambridge Institute, has been named the 2022 recipient of The Society of Memorial Sloan Kettering Prize.
When Memorial Sloan Kettering Cancer Center (MSK) opened its doors along Commack Road in 2002, eastern Long Islanders no longer needed to navigate congested roadways and train lines bound for Manhattan to receive personalized cancer care. Today, more than 14 years later, MSK is reinforcing its commitment to the local community in the form of a 38,000-plus-square-foot addition complete with enhancements to both clinical programs and physical spaces.
Memorial Sloan Kettering announced the appointment of Pereira & O’Dell in New York as its creative agency of record and Media Storm as its media agency of record.
MSK physicians and scientists are involved in notable research to be presented during the virtual meeting.